´ëÇÑÁ¾¾ç³»°úÇÐȸ BEST of WCLC 2019 : 2019-11-30±³À°ÀÏÀÚ : 2019-11-30
±³À°Àå¼Ò : ±×·£µå¿öÄ¿Èú ºñ½ºÅ¸È¦ (B2)
±³À°ÁÖÁ¦ :
BEST of WCLC 2019ÁÖÃÖ±â°ü : ´ëÇÑÁ¾¾ç³»°úÇÐȸ(17.5 ¸íĪº¯°æ Çѱ¹ÀÓ»ó¾ÏÇÐȸ)
´ã´çÀÚ : ´ëÇÑÁ¾¾ç³»°úÇÐȸ »ç¹«±¹
¿¬¶ôó : 02-735-2857
À̸ÞÀÏ :
ksmo3@ksmo.or.kr ±³À°Á¾·ù : ÈäºÎ¿Ü°ú, ¿µ»óÀÇÇаú, ¹æ»ç¼±Á¾¾çÇаú, º´¸®°ú
Âü¼®¿¹»óÀοø : 300¸í
Èñ¸ÁÆòÁ¡ : 6Á¡
Áö¿ª :
¼¿ïƯº°½Ã±³À°½Ã°£ : 7 ½Ã°£ 20ºÐ
¼¼ºÎ¼ö°·á : 80,000¿ø
ºñ°í »çÀüµî·Ï : Àü¹®ÀÇ 50,000 / ÀüÀÓÀÇ 30,000 / ±âŸ 70,000¿ø´çÀϵî·Ï : Àü¹®ÀÇ 60,000 / ÀüÀÓÀÇ 40,000 / ±âŸ 80,000¿ø
±¸ºÐ ¿ùÀÏ °ÀÇ½Ç ½Ã°£ ±³À°Á¦¸ñ °»ç¸í(¼Ò¼Ó) Çʼö°ú¸ñ
±³À°½Ã°£ 11-30 Room A 08:50~09:30 New Standards of Care in post crizotinib ALK+NSCLC : roles of brigatinib in optimal sequential treatments È«¹ÎÈñ(¿¬¼¼¾Ïº´¿ø)
±³À°½Ã°£ 11-30 Room A 09:30~09:50 New Threat of Lung cancer À̰迵(°Ç±¹´ëÇб³º´¿ø)
±³À°½Ã°£ 11-30 Room A 09:50~10:10 Update of lung cancer screening at WCLC2019 ±èÅÂÁ¤(»ï¼º¼¿ïº´¿ø)
±³À°½Ã°£ 11-30 Room A 10:10~10:30 Update of Surgery at WCLC2019 TBD(TBD)
±³À°½Ã°£ 11-30 Room A 10:30~10:50 Evolution of Tissue Testing for Immuno-oncology or Precision oncology ÀüÀ±°æ(¼¿ï´ëÇб³º´¿ø)
±³À°½Ã°£ 11-30 Room A 10:50~11:10 New approach of Immunotherapy for cure of lung cancer À̼¼ÈÆ(»ï¼º¼¿ïº´¿ø)
±³À°½Ã°£ 11-30 Room A 11:10~11:30 Precision trials of lung cancer at WCLC2019 ¹Î¿µÁÖ(¿ï»ê´ëÇб³º´¿ø)
Åä·Ð 11-30 Room A 11:30~11:40 Q&A ()
±³À°½Ã°£ 11-30 Room A 11:40~12:30 Optimal treatment strategy to prolong survival in 1st line for EGFR mutant NSCLC patients ±èŹÎ(¼¿ï´ëÇб³º´¿ø)
ÈÞ½Ä 11-30 Room A 12:30~13:00 Coffee Break ()
±³À°½Ã°£ 11-30 Room A 13:00~13:20 Immunotherapy for locoregional disease ±è¹Ì¼Ò(¼¿ï´ëÇб³º´¿ø)
±³À°½Ã°£ 11-30 Room A 13:20~13:40 Optimal management for oligometastitc NSCLC ÀÓäȫ(°í·Á´ëÇб³¾È»êº´¿ø)
±³À°½Ã°£ 11-30 Room A 13:40~14:00 Management of N2 disease in the era of IO ¹Ú¼º¿ë(½ÅÃ̼¼ºê¶õ½ºº´¿ø)
Åä·Ð 11-30 Room A 14:00~14:20 Discussion ()
±³À°½Ã°£ 11-30 Room A 14:20~15:00 Targeted Therapy and Chemotherapy ÃÖÀ±Áö(°í·Á´ëÇб³¾È¾Ïº´¿ø)
±³À°½Ã°£ 11-30 Room A 15:00~15:30 Immuno-Oncology À±½Å±³(¼¿ï¾Æ»êº´¿ø)
ÈÞ½Ä 11-30 Room A 15:30~16:00 Coffee Break ()
±³À°½Ã°£ 11-30 Room A 16:00~16:30 Small Cell Lung Cancer È«¼÷Èñ(¼¿ï¼º¸ðº´¿ø)
±³À°½Ã°£ 11-30 Room A 16:30~16:55 Thymic Malignacy/Mesothelioma ÀÓ½ÂÅÃ(¿øÁÖ¼¼ºê¶õ½º±âµ¶º´¿ø)
Åä·Ð 11-30 Room A 16:55~17:10 Discussion ()